Table 2.
Participant characteristics by emergency contraception use in cancer survivors (n=616)a
| Characteristic | Emergency Contraception Use No. (%) (N=156) | No Emergency Contraception Use No. (%) (N=460) | P-value |
|---|---|---|---|
|
| |||
| Current age (y) | <0.001 | ||
| 18 – 24 | 11 (7.2) | 24 (5.4) | |
| 25 – 30 | 55 (36.2) | 83 (18.5) | |
| 31 – 35 | 51 (33.6) | 164 (36.5) | |
| 36 – 41 | 35 (23.0) | 178 (39.6) | |
|
| |||
| Race | 0.02 | ||
| White | 103 (66.0) | 348 (75.7) | |
| Black or African American | 7 (4.5) | 7 (1.5) | |
| Other | 46 (29.5) | 105(22.8) | |
|
| |||
| Hispanic ethnicity | 45 (28.9) | 100 (21.7) | 0.07 |
|
| |||
| BMI (kg/m2) | 0.14 | ||
| <18.5 | 40 (26.9) | 111 (24.7) | |
| 18.5–24.9 | 72 (48.3) | 190 (42.2) | |
| 25–29.9 | 13 (8.7) | 72 (16.0) | |
| > 30 | 24 (16.1) | 77 (17.1) | |
|
| |||
| Education | 0.79 | ||
| Did not complete college | 38 (24.4) | 117 (25.4) | |
| College graduate and beyond | 118 (75.6) | 343 (74.6) | |
|
| |||
| Income | 0.32 | ||
| <$51,000 | 45 (28.8) | 113 (24.6) | |
| ≥$51,000 | 105 (67.3) | 317 (68.9) | |
|
| |||
| Years since cancer diagnosis | 0.04 | ||
| ≤2 | 11 (7.1) | 63 (13.7) | |
| >2–5 | 36 (23.1) | 122 (26.5) | |
| >5 | 109 (69.9) | 275 (59.8) | |
|
| |||
| Cancer diagnosisb | 0.001 | ||
| Breast | 18 (11.5) | 119 (25.9) | |
| Leukemia and lymphomas | 52 (33.3) | 154 (33.5) | |
| Gynecologic | 14 (9.0) | 34 (7.4) | |
| Gastrointestinal | 3 (1.9) | 12 (2.6) | |
| Bone and soft tissue tumors | 14 (9.0) | 24 (5.2) | |
| Skin | 8 (5.1) | 16 (3.5) | |
| Thyroid | 47 (30.1) | 101 (22.0) | |
|
| |||
| Surgery for cancer | 100 (64.1) | 318 (69.1) | 0.25 |
|
| |||
| Chemotherapy | 87 (55.8) | 297 (64.6) | 0.05 |
|
| |||
| Radiation therapy | 72 (46.2) | 233 (50.7) | 0.33 |
|
| |||
| Bone marrow or stem cell transplant | 4 (2.6) | 23 (5.0) | 0.09 |
|
| |||
| Partnered relationship | 91 (58.3) | 355 (77.2) | <0.001 |
|
| |||
| Ever been pregnant | 64 (41.0) | 248 (53.9) | 0.005 |
|
| |||
| Ever had live birth | 50 (32.1) | 212 (46.1) | 0.002 |
a
Numbers do not sum up to 616 for some variables due to missing data.
b
Gynecologic cancer = cervix, uterus, ovary; Gastrointestinal cancer = pancreas, gallbladder, stomach, small intestine, colon, appendix, rectum